TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 25 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $952,000 | -30.8% | 4,139,924 | +7.8% | 0.00% | – |
| Q4 2021 | $1,375,000 | -29.8% | 3,839,725 | +17.9% | 0.00% | – |
| Q3 2021 | $1,958,000 | -43.2% | 3,257,565 | +4.8% | 0.00% | -100.0% |
| Q2 2021 | $3,450,000 | +324.4% | 3,108,226 | +389.1% | 0.00% | – |
| Q1 2021 | $813,000 | +356.7% | 635,539 | +141.7% | 0.00% | – |
| Q4 2020 | $178,000 | -15.6% | 262,985 | +4.8% | 0.00% | – |
| Q3 2020 | $211,000 | +486.1% | 250,858 | +327.4% | 0.00% | – |
| Q2 2020 | $36,000 | +89.5% | 58,699 | +119.7% | 0.00% | – |
| Q1 2020 | $19,000 | – | 26,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|